Potential prion risks & clearance by filtration - Strategies for process validation

被引：0
|
作者：
Aranha, H
Martin, J
机构：
[1] Pall Corp, Sci & Lab Serv Dept, Port Washington, NY USA
[2] Pall Life Sci, Biopharmaceut Grp, Port Washington, NY USA
来源：
GENETIC ENGINEERING NEWS | 2001年 / 21卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：58 / 59
页数：2
相关论文
共 50 条
  • [1] Clearance of poliovirus and prion protein by virus filtration.
    Reinert, J
    Felice, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U134 - U134
  • [2] Prion clearance capacity is improved by modification of a filtration step in the Gamunex® (IGIV) manufacturing process.
    Mink, Michael
    Hartwell, Randal
    Bauman, Patricia
    Burdick, Michael
    Kislan, Michele
    Nelson, Mark
    Oquendo, Renea'
    Pifat, Dominique
    Cai, Kang
    BLOOD, 2006, 108 (11) : 42B - 42B
  • [3] Filtration virus-removal in process validation - Clearance of viruses with ultipor VF filters
    Aranha-Creado, H
    GENETIC ENGINEERING NEWS, 2000, 20 (06): : 64 - 64
  • [4] Current strategies for bioprocess validation - Viral clearance and prion removal key for emerging gene and cell therapies
    Glaser, V
    GENETIC ENGINEERING NEWS, 2001, 21 (02): : 15 - +
  • [5] Virus removal by filtration: Comparison of batch and continuous operation - virus clearance validation and process scaling
    Hansmann, Bjoern
    Kleindienst, Birte
    Manzke, Anika
    Kosiol, Peter
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [6] Roundup on bioprocess validation issues - Viral clearance and filtration
    Martin, J
    GENETIC ENGINEERING NEWS, 2000, 20 (01): : 55 - 55
  • [7] Viral clearance strategies for biopharmaceutical safety - Part 2: Filtration for viral clearance
    Aranha, H
    BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 2001, 14 (02): : 32 - +
  • [8] Viral Clearance Strategies for Biopharmaceutical Safety: Part II: A Multifaceted Approach to Process Validation
    Aranha, Hazel
    Forbes, Sharlene
    Pharmaceutical Technology, 2001, 25 (06): : 26 - 43
  • [9] Viral clearance strategies for biopharmaceutical safety - Part 3. A multifaceted approach to process validation
    Aranha, H
    Forbes, S
    BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 2001, 14 (05): : 42 - +
  • [10] Efficient process strategies for compressible cake filtration
    Alles, CM
    Anlauf, H
    CHEMIE INGENIEUR TECHNIK, 2003, 75 (09) : 1221 - 1230
12345